AMAG Pharmaceuticals, Inc. News Releases http://ir.amagpharma.com/ AMAG Pharmaceuticals, Inc. News Releases en AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-host-analyst-day-may-22-2019-new-york WALTHAM, Mass. , May 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 22, 2019 from 8:30 a.m. to 12:00 p.m. Eastern Time . Members of AMAG’s management team and key opinion leaders Fri, 17 May 2019 08:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16831 AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-announces-first-quarter-2019-financial Achieved record Feraheme revenue growth and more than 50% market share for Makena auto-injector Completed integration of Perosphere Pharmaceuticals Inc. and progressed ciraparantag clinical program Reaffirms 2019 financial guidance Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass. Tue, 07 May 2019 07:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16806 AMAG Pharmaceuticals Presents New Data at the American College of Obstetricians and Gynecologists Annual Meeting http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-presents-new-data-american-college WALTHAM, Mass. , May 03, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it will present new data related to investigational drug bremelanotide for the treatment of hypoactive sexual desire disorder (HSDD) and Feraheme® (ferumoxytol) related to iron deficiency Fri, 03 May 2019 08:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16791 AMAG Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019 at 8:00 a.m. ET http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-host-first-quarter-2019-financial-results WALTHAM, Mass. , April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 Tue, 30 Apr 2019 08:05:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16776 AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4) http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-announces-grant-inducement-awards-under WALTHAM, Mass. , April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an option to purchase 15,000 shares of common stock and (ii) 7,500 restricted stock units. Tue, 30 Apr 2019 08:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16771 AMAG Pharmaceuticals Appoints Nancy Griffith, PH.D., as Vice President of Scientific Communications and Medical Operations http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-appoints-nancy-griffith-phd-vice-president WALTHAM, Mass. , April 16, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Nancy Griffith , Ph.D., as vice president, scientific communications and medical operations, reporting to Brian Robinson, M.D., senior vice president, medical affairs. Dr. Tue, 16 Apr 2019 08:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16766 AMAG Pharmaceuticals Appoints New Members to Board of Directors http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-appoints-new-members-board-directors WALTHAM, Mass. , April 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the election of two new members to its Board of Directors—Anne Phillips, M.D., senior vice president, clinical development, medical and regulatory affairs for Novo Nordisk, Inc. Fri, 12 Apr 2019 08:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16726 AMAG Pharmaceuticals to Present at Needham 18th Annual Healthcare Conference http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-present-needham-18th-annual-healthcare WALTHAM, Mass. , April 02, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Ted Myles , chief financial officer, will present at the Needham 18 th Annual Healthcare Conference in New York City on Tuesday, April 9, 2019 at 4:10 p.m. Tue, 02 Apr 2019 08:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16681 March of Dimes and AMAG Pharmaceuticals, Inc., Announce First Joint Supportive Pregnancy Care Program http://ir.amagpharma.com/news-releases/news-release-details/march-dimes-and-amag-pharmaceuticals-inc-announce-first-joint First Site Launches in Springfield, Mass. Offering an Innovative Model of Group Prenatal Care ARLINGTON, Va. and WALTHAM, Mass. , March 20, 2019 (GLOBE NEWSWIRE) -- March of Dimes and AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced Baystate Medical Center’s Wesson Women’s Clinic in Wed, 20 Mar 2019 08:00:00 -0400 AMAG Pharmaceuticals, Inc. News Releases 16671 AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena® (hydroxyprogesterone caproate injection) http://ir.amagpharma.com/news-releases/news-release-details/amag-pharmaceuticals-announces-topline-results-prolong-trial WALTHAM, Mass. , March 08, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today topline results from PROLONG (Progestin’s Role in Optimizing Neonatal Gestation), a randomized, double-blinded, placebo-controlled clinical trial evaluating Makena® in patients with a Fri, 08 Mar 2019 08:00:00 -0500 AMAG Pharmaceuticals, Inc. News Releases 16656